Dynamic behavior of the p53-Mdm2 core module under the action of drug Nutlin and dual delays

Juenu Yang1, Fang Yan1, Haihong Liu1

  • 1Department of Mathematics, Yunnan Normal University, Kunming 650500, China.

Insights

Nutlin drugs targeting the p53 pathway can cause oscillations. Time delays and key parameters influence the amplitude and period of p53 oscillation, offering insights into cancer treatment.

Area of Science:

  • Systems biology
  • Pharmacology
  • Cancer research

Background:

  • Nutlin drugs target the p53 pathway by inhibiting Mdm2, leading to p53 accumulation.
  • The integrated Nutlin PBK and p53 pathway involves complex feedback loops, including Mdm2 mRNA positive feedback and Mdm2 protein negative feedback.

Purpose of the Study:

  • To investigate how time delays and parameter variations affect the oscillatory behavior of the integrated Nutlin PBK and p53 pathway.
  • To analyze the stability and Hopf bifurcation of the system's equilibrium point.

Main Methods:

  • Application of bifurcation theory and Hopf bifurcation analysis.
  • Utilizing normal form theory and central manifold theorem.
  • Numerical simulations and theoretical calculations.

Main Results:

  • Time delays and key network parameters significantly impact the amplitude and period of p53 oscillations.
  • Explicit criteria for Hopf bifurcation direction and stability were established.
  • The study identified critical factors influencing oscillatory dynamics in the p53 pathway.

Conclusions:

  • Time delays and system parameters are crucial for understanding p53 oscillation dynamics.
  • Findings provide a better understanding of p53 pathway functions.
  • Results offer potential clues for developing novel cancer therapies targeting the p53 pathway.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.6K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K